Corlife develops new products for surgery driven by the idea even that well-established procedures harbor significant potential for innovation. As an independent company, we avail of our own resources for development, registration, and production in clean rooms. The founders are experienced professionals from the clinical and industry sectors who can identify medical needs, while appropriately assessing feasibility.
Corlife is specialized in stented and stentless devices based on tissue-engineered matrix composites which integrate into the patients body, becoming indistinguishable from the patients own tissue. Corlife’s proprietary technologies are based on various international patents and patent applications.
Corlife was founded by experienced medical experts. The company adheres to the standard EN 13485 an is a tissue establishment in compliance with the European Directives.